Patents
Patents for C07C 275 - Derivatives of urea, i.e. compounds containing any of the groups the nitrogen atoms not being part of nitro or nitroso groups (9,848)
09/2009
09/24/2009WO2009115040A1 Benzoylurea compounds bearing heptafluoroisopropyl and uses thereof
09/24/2009WO2009053443A3 Indane compounds
09/24/2009US20090239841 Diaryl Ureas as CB1 Antagonists
09/24/2009CA2728756A1 Modulators of the prostacyclin (pgi2) receptor useful for the treatment of disorders related thereto
09/23/2009EP2103601A1 Process for production of phenylalanine derivatives having quinazolinedione skeletons and intermediates for the production
09/23/2009EP2102147A1 CHIRAL CYCLIC ß-AMINO ACIDS AND THEIR DERIVATES, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND THE USE OF SUCH COMPOUNDS
09/23/2009EP1590322B1 Carbonyl-amino substituted acyl phenyl urea derivatives, method for the production and use thereof
09/23/2009CN101538483A Poly-generation technique for using coal gas and coke oven gas as raw materials
09/23/2009CN101538227A Compound containing sevoflurane isopropyl benzoyl urea and application thereof
09/23/2009CN101538200A Urea-, glycerate- and, hydroxyamide-headed hydrocarbon chain lyotropic phases forming surfactants
09/16/2009EP2100876A2 New compounds for the inhibition of rotamases and use thereof
09/16/2009EP1523471B1 Urea-substituted and urethane-substituted acylureas, methods for the production thereof and their use as medicaments
09/16/2009EP1472541B1 Imaging agents and methods of imaging naaladase of psma
09/16/2009CN101531620A Method for preparing methoxyl-isourea hydrosulfate
09/16/2009CN100540547C Inhibitors of histone deacetylase
09/15/2009US7588880 Phenylglyoxylic acid type of low volatility, excellent initiator properties, dark-storage stability of formulations; used in thermally and photochemically curable component mixtures; binds in coating to prevent migration; addition-condensation polymers; photoresists; electronics; inks; adhesives; cables
09/10/2009US20090227631 2-adamantylurea derivatives as selective 11beta-hsd1 inhibitors
09/09/2009EP2097111A2 Heterodimers of glutamic acid
09/09/2009EP1610779B1 3-oxo-1,3-dihydro-indazole-2-carboxylic acid amide derivatives as phospholipase inhibitors
09/09/2009CN100537527C Aryl and biaryl compounds having MCH modulatory activity
09/09/2009CN100537526C Polyisocyanates with biuret structure, blocked with secondary amines
09/09/2009CN100536839C Urea derivatives as integrin alpha 4 antagonists
09/08/2009CA2360360C Piperidyl benzamide compounds, composition containing same and their use thereof
09/03/2009WO2009106351A1 Derivatives of 4-(2-amino-1-hydroxyethyl) phenol as agonists of the b2 adrenergic receptor
09/03/2009US20090221424 Pesticides
09/03/2009CA2716397A1 Derivatives of 4-(2-amino-1-hydroxyethyl)phenol as agonists of the .beta.2 adrenergic receptor
09/02/2009EP2096105A1 Derivatives of 4-(2-amino-1-hydroxyethyl)phenol as agonists of the b2 adrenergic receptor
09/02/2009EP2094653A1 O-substituted-dibenzyl urea-derivatives as trpv1 receptor antagonists
09/02/2009EP2094643A2 N-((3-benzyl)-2,2-(bis-phenyl)-propan-1-amine derivatives as cetp inhibitors for the treatment of atherosclerosis and cardiovascular diseases
09/01/2009US7582668 to treat cellular proliferative diseases, hyperplasias, solid tumor, cardiac hypertrophy, immune disorders and inflammation; modulators of one or more mitotic kinesins; N-(2-(2-dimethylamino-acetylamino)-1-{4-[8-(1-hydroxy-ethyl)-imidazo[1,2-a]pyridin-2-yl]-benzyl}-ethyl)-3-chloro-4-isopropoxy-benzamide
08/2009
08/27/2009WO2008116145A3 Soluble epoxide hydrolase inhibitors
08/27/2009US20090215902 Methods for the treatment of dermatological disorders
08/26/2009EP2091929A1 Agents that disrupt cellular replication and their use in inhibiting pathological conditions
08/26/2009CN101516840A Substituted acylanilides and methods of use thereof
08/25/2009US7579378 Sulfonamido compounds that antagonize the vanilloid TRPV1 receptor
08/20/2009US20090209514 Tetrahydro-Naphthalene Derivatives as Vanilloid Receptor Antagonists
08/19/2009CN101511780A Derivatives of 4-trimethylammonium-3-aminobutyrate and 4-trimethylphosphonium-3-aminobutyrate as CPT-inhibitors
08/18/2009US7576245 Using a fluorinated phenyl compound containing electrophilic and nucleophilic groups; increasing the fluorous nature of an organic compound; 4-(1H,1H,2H,2H-Perfluorodecyl)benzenesulfonamide; N-[4-(1H,1H,2H,2H-perfluorodecyl)benzyloxycarbonyloxy]succinimide
08/18/2009US7576239 Substituted amides
08/18/2009US7576238 Process for the preparation of substituted tetralin and substituted indane derivatives
08/18/2009US7576175 Alpha-4 beta-1 integrin ligands for imaging and therapy
08/13/2009US20090203906 4-[((4-carboxybutyl){2-[2-({4-[2-(4-hydroxyphenyl)ethyl]benzyl}oxy)phenyl]-ethyl}amino)methyl]benzoic acid, which stimulate soluble guanylate cyclase via a novel mechanism of action, used for the treatment of cardiovascular disorders and fibrotic disorders
08/12/2009EP1784387A4 Phenol compound, reversible thermosensitive recording medium, reversible thermosensitive recording label, reversible thermosensitive recording member, image-processing apparatus and image-processing method
08/11/2009US7572790 Biphenyl carboxylic amide p38 kinase inhibitors
08/11/2009CA2368688C Novel inhibitors of formation of advanced glycation endproducts (age's)
08/06/2009WO2009096526A1 Carboxylic acid compound or salt thereof
08/06/2009WO2009096505A1 Agent for improving attention and concentration powers
08/06/2009WO2009095164A1 Method for producing urethanes
08/06/2009US20090197965 Compounds, compositions and methods for the treatment of amyloid diseases and synucleinopathies such as alzheimer's disease, type 2 diabetes, and parkinson's disease
08/06/2009DE102008006881A1 Verfahren zur Herstellung von Urethanen A process for the preparation of urethanes
08/05/2009CN101500986A Di-aromatic substituted amides as inhibitors for GLYT1
08/05/2009CN100522934C Omega-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors
08/05/2009CN100522907C Method for producing aromatic compound dimer
08/05/2009CN100522151C Compounds for treatment of inflammation, diabetes and related disorders
08/04/2009CA2434228C Biphenyl derivatives
07/2009
07/30/2009US20090192192 Inhibitors of biofilm formation of gram-positive and gram-negative bacteria
07/30/2009US20090192096 2'-Substituted 1,1'-Biphenyl-2-Carboxamides, Processes For Their Preparation, Their Use As Medicaments, And Pharmaceutical Preparations Comprising Them
07/29/2009EP1893668B1 N-(2-hydroxyalkanoyl) -n,n'-dialkylureas and a process for their preparation
07/22/2009EP1299354B1 Factor viia inhibitory (thio)urea derivatives, their preparation and their use
07/21/2009USRE40861 4-Trimethylammonium-3-(nonylcarbamoyl)-aminobutyrate; hypoglycemic agents; antidiabetic agents; antiischemic agents; congestive heart failure; obesity
07/16/2009WO2009089541A2 A new inhibitor scaffold for the inhibition of the enzyme phosphoenolpyruvate carboxykinase
07/16/2009WO2009089192A1 2-phenyl phenoxyacetic acids useful for treating inflammatory disorders
07/16/2009WO2009034308A3 Process for the preparation of a raf kinase inhibitor and intermediates for use in the process
07/16/2009US20090181971 Inhibitors of Histone Deacetylase
07/15/2009EP1631261B1 Production of small particles
07/15/2009CN101481336A Preparation of N-carbamoyl-aminoglutaric acid and sodium salt thereof
07/14/2009US7560587 gel agents for hot melt or phase change inks; lower melting point; scratch resistance;
07/14/2009CA2487705C Low-cure powder coatings and methods for using the same
07/09/2009WO2009086429A1 Soluble epoxide hydrolase inhibitors
07/09/2009US20090176786 Benzoylurea Compounds and Use Thereof
07/09/2009US20090176307 Compounds, Compositions and Methods
07/09/2009US20090176095 Novel triphenylmethane derivative, organic gellant containing the same, organic gel, and organic fiber
07/08/2009CN101475513A Raf and HDAC small molecular double inhibitor, and preparation and use thereof
07/07/2009US7557102 Pyrazolidine-1,2-dicarboxyldiphenylamide derivatives as coagulation factor Xa inhibitors for the treatment of thromboses
07/02/2009WO2009081892A1 Novel catechol derivative, pharmaceutical composition containing the same, and use of those
07/02/2009US20090171112 Urea derivative and process for preparing the same
07/01/2009EP1537075B1 Diarylurea derivatives and their use as chloride channel blockers
07/01/2009CN100506776C NK1 antagonists
06/2009
06/30/2009US7553963 Liquid partially trimerized and allophanized polyisocyanates based on toluene diisocyanate and diphenylmethane diisocyanate
06/30/2009US7553831 Beta-secretase inhibitors; inhibiting cleavage of amyloid precursor protein (APP); hydroxy-functional disubstituted amines such as 6-(([[(2S,3S)-4-(3,5-difluorophenyl)-3-((3-[(dipropylamino)carbonyl]benzoyl)amino)-2-hydroxybutyl](ethyl)amino]carbonyl)amino)hexanoic acid
06/30/2009CA2254693C Process for the preparation of aminoalcohol derivatives and their further conversion to (1r,4s)-4-((2-amino-6-chloro-5-formamido-4-pyrimidinyl)amino)-2-cyclopentenyl-1-methanol
06/25/2009US20090163543 Histone Deacetylase Inhibitors and Methods of Use Thereof
06/25/2009US20090163496 Antibacterial agents
06/24/2009EP1558567B1 Novel amide compounds with mch antagonistic effect and medicaments comprising said compounds
06/23/2009US7550489 N-[3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl]-2-(5-trifluoromethyl-2-pyridyloxy)-2-methylpropanamide and phentermine, metformin, or bupropion; obesity; antipsychotic agents; synergistic; cannabinoid receptor antagonists
06/18/2009WO2009015485A8 Cyclic inhibitors of carnitine palmitoyltransferase and treating cancer
06/18/2009WO2008156816A3 Renin inhibitors
06/11/2009WO2009072798A1 High adhesive acrylate monomer and method for preparing the same
06/11/2009WO2009071533A1 Polyisocyanates containing allophanate groups
06/11/2009US20090149445 Tricyclic steroid hormone nuclear receptor modulators
06/10/2009EP2066620A1 Di-aromatic substituted amides as inhibitors for glyt1
06/10/2009EP1474385B1 Urea linker derivatives for use as ppar modulators
06/10/2009CN101454277A New materials for lithographic plates coatings, lithographicplates and coatings containing same, methods of preparation and use
06/10/2009CN100497302C Diarylurea derivatives and their use as chloride channel blockers
06/09/2009US7544716 N-(7-hydroxy-5,6,7,8-tetrahydronaphthalen-1-yl)-N'-[3-piperidin-1-yl-4-(trifluoromethyl)benzyl]urea; urinary incontinence, overactive bladder, pain, nerve injury, ischemia, neurodegeneration, stroke, inflammatory disorders, asthma and chronic obstructive pulmonary disease
06/04/2009WO2009069132A2 Novel reverse transcriptase inhibitors
06/04/2009US20090143592 Glucagon Antagonists/Inverse Agonists
06/04/2009US20090143374 Use of Compounds and Compositions for the Treatment of Amyloid Diseases
06/03/2009EP2065365A2 Functional monomers for molecular recognition and catalysis
06/03/2009CN100494170C Preparing process of L-2-(3,4-dimethoxy benzyl)-2-ureido propionic acid
1 ... 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 ... 99